Everlinq Reports Successful New Approach to Vascular Access

The everlinQ^TM System forms an HD access with radiofrequency energy at sites not traditionally used by surgeons. The system has CE Mark approval, but is not yet available in the U.S.

Read the full article » | Posted 12-10-2015

Related Articles

• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026
• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026